KIORA PHARMACEUTICALS, INC. (KPRX) Net margin 2016–2024
KIORA PHARMACEUTICALS, INC. (KPRX) net profit margin by fiscal year — reported net income divided by reported revenue.
22.4%FY2024 · since FY2016: -1993.8% → 22.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 22.4% | — |
| FY2020 | -56901.7% | -56637.4 pp |
| FY2019 | -264.2% | +390.0 pp |
| FY2018 | -654.2% | +2589.3 pp |
| FY2017 | -3243.5% | -1249.8 pp |
| FY2016 | -1993.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More KPRX financial trends
KPRX RevenueKPRX Net incomeKPRX Gross profitKPRX Gross marginKPRX Operating incomeKPRX Operating marginKPRX Operating cash flowKPRX Free cash flowKPRX Capital expendituresKPRX Return on equityKPRX Stock buybacksKPRX Dividends paidKPRX Total assetsKPRX Total liabilitiesKPRX Shareholders’ equityKPRX overview →